Publication | Open Access

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer

MedicineCancer ManagementGynecologySafety AnalysisFinal Overall SurvivalCancer TreatmentOncologyRadiation OncologyGynecology OncologyPhase 3Ovarian Cancer